Vedolizumab for the treatment of Crohn’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vedolizumab for the treatment of Crohn’s disease

Published:2018-02-23 Issue:3 Volume:14 Page:179-189
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Argollo Marjorie¹²^ORCID,Fiorino Gionata²,Peyrin-Biroulet Laurent³,Danese Silvio²⁴

Affiliation:

1. Department of Gastroenterology, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil

2. IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Milan, Italy

3. Department of Gastroenterology and Inserm U954, Nancy University Hospital, Lorraine University, Vandoeuvre, France

4. Department of Biomedical Sciences, Humanitas University, Milan, Italy

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2018.1438189

Reference62 articles.

1. Crohn's disease

2. Inflammatory bowel disease: clinical aspects and established and evolving therapies

3. Inflammatory bowel disease: past, present, and future

4. Inflammatory bowel disease: cause and immunobiology

5. Genetics and pathogenesis of inflammatory bowel disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vedolizumab in the treatment of Crohn's disease: A promising therapeutic approach;Drug Development Research;2024-06

2. Tissue–Resident Memory T Cells in Chronic Inflammation—Local Cells with Systemic Effects?;Cells;2021-02-16

3. Pathophysiology of Crohn’s disease inflammation and recurrence;Biology Direct;2020-11-07

4. Choosing the most appropriate biologic therapy for Crohn’s disease according to concomitant extra-intestinal manifestations, comorbidities, or physiologic conditions;Expert Opinion on Biological Therapy;2019-11-10

5. Prevention of Postoperative Recurrence in CD: Tailoring Treatment to Patient Profile;Current Drug Targets;2019-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3